Opioid contracts and random drug testing for people with chronic pain - Think twice

Journal of Law, Medicine and Ethics

Volumn 37, Issue 4, 2009, Pages 841-845

  Collen, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTICLE; CHRONIC DISEASE; CONTRACT; DOCTOR PATIENT RELATION; ETHICS; HUMAN; LEGAL ASPECT; OPIATE ADDICTION; PAIN; PATIENT RIGHT; SUBSTANCE ABUSE; TRUST; UNITED STATES;

ANALGESICS, OPIOID; CHRONIC DISEASE; CONTRACTS; HUMANS; OPIOID-RELATED DISORDERS; PAIN; PATIENT RIGHTS; PHYSICIAN-PATIENT RELATIONS; SUBSTANCE ABUSE DETECTION; TRUST; UNITED STATES;

EID: 76149106842     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2009.00455.x     Document Type: Article

References (79)

1. B. Breuer, M. Pappagallo, and R. Portenoy, A national Survey on Pain Management Practices in the United States, 2006 Annual Meeting of the American Pain Society, American Pain Society Website, available at http://www.ampainsoc. org/db2/abstract/view?poster-id=3007#100 last visited October 11, 2009).
2. S. M. Fishman, T. B. Bandman, A. Edwards, and D. Borsook, "The Opioid Contract in the Management of Chronic Pain Journal of Pain and Symptom Management 18, no. 1 (1999 27 37, at 31.
3. R. M. Arnold, P. K. Han, and D. Seltzer, "Opioid Contracts in Chronic Nonmalignant Pain Management: Objectives and Uncertainties American Journal of Medicine 119, no. 4 (2006 292 296, at 293)
4. A. N. Nafziger and J. S. Bertino Jr., "Utility and Application of Urine Drug testing in Chronic Pain Management with Opioids," Clinincial Journal of Pain 25, no. 1 (2009): 73-9, at 73.
5. G. M. Reisfield, E. Salazar, and R. L. Bertholf, "Rational Use and Interpretation of Urine Drug Testing in Chronic Opioid Therapy Annals of Clinical & Laboratory Science 37, no. 4 (2007 301 314, at 301)
6. H. A. Heit, and D. L. Gourlay, "Urine Drug Testing in Pain Medicine," Journal of Pain and Symptom Management 27, no. 3 (2004): 260-7, at 261; see Nafziger et al., supra note 3, at 73.
7. N. P. Katz, S. Sherburne, M. Beach, R. J. Rose, J. Vielguth, J. Bradley, and G. J. Fanciullo, "Behavioral Monitoring and Urine Toxicology Testing in Patients Receiving Long-term Opioid Therapy Anesthesia & Analgesia 97, no. 4 (2003 1097 1102, at 1097
8. N. Katz and G. J. Fanciullo, "Role of Urine Toxicology Testing in the Management of Chronic Opioid Therapy," Clininical Journal of Pain 18, no. 4, Supplement (2002): S76-82, at S76.
9. D. L. Gourlay, H. A. Heit, and A. Almahrezi, "Universal Precautions in Pain Medicine: A Rational Approach to the Treatment of Chronic Pain," Pain Medicine 6, no. 2 (2005): 107-12, at 108; see Nafziger et al., supra note 3, at 73
10. S. D. Passik and K. L. Kirsh, "The Interface between Pain and Drug Abuse and the Evolution of Strategies to Optimize Pain Management While Minimizing Drug Abuse Experimental and Clinical Psychopharmacology 16, no. 5 (2008 400 404, at 404.
11. See Arnold et al., supra note 3, at 292.
12. See Fishman et al., supra note 2, at 28; Arnold et al., supra note 3, at 292.
13. S. M. Fishman, and P. G. Kreis, "The Opioid Contract Clinical Journal of Pain 18, no. 4, Supplement (2002 S70-5, at S72; see Fishman et al., supra note 2, at 28.
14. See Arnold et al., supra note 3, at 293.
15. S. M. Fishman, B. Wilsey, J. Yang, G. M. Reisfield, T. B. Bandman, and D. Borsook, "Adherence Monitoring and Drug Surveillance in Chronic Opioid Therapy Journal of Pain and Symptom Management 20, no. 4 (2000 293 307, at 297; see Arnold et al., supra note 3, at 294.
16. B. A. Garner, ed., Blacks Law Dictionary, 7th ed. (St. Paul : West Group, 1999 at 318.
17. J. M. Perillo, Corbin on Contracts, vol. 7 (Newark : Matthew Bender & Company, Inc., 1998 at 376, 387.
18. P. Salmon, and B. Young, "Dependence and Caring in Clinical Communication: The Relevance of Attachment and Other Theories Patient Education and Counseling 74, no. 3 (2009 331 338, at 332.
19. M. McCoy, "Autonomy, Consent, and Medical Paternalism: Legal Issues in Medical Intervention," Journal of Alternative and Complementary Medicine 14, no. 6 (2008): 785-92, at 786
20. C. Spanswick, "What Chronic Pain Looks Like to the Clinician in S. Rashiq, D. Schopflocher, P. Taenzer, E. Jonsson, eds., Chronic Pain: A Health Policy Perspective (Federal Republic of Germany : WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, 2008 at 94-6.
21. M. R. Dibben, S. E. Morris, and M. E. Lean, "Situational Trust and Co-operative Partnerships Between Physicians and Their Patients: A Theoretical Explanation Transferable from Business Practice," Quarterly Journal of Medicine 93, no. 1 (2000): 55-61, at 55
22. E. Schei, "Doctoring as Leadership: The Power to Heal," Perspectives in Biology and Medicine 49, no. 3 (2006): 393-406, at 397
23. B. Breuer, M. Pappagallo, J. Y. Tai, and R. K. Portenoy, "U.S. Board-Certified Pain Physician Practices: Uniformity and Census Data of their Locations Journal of Pain 8, no. 3 (2007 244 250, at 248.
24. See Fishman et al., supra note 2, at 32.
25. American Jurisprudence, 2nd ed., vol. 17A (Danvers : Thomson West, 2004 at 343-5.
26. S. E. Roskos, A. J. Keenum, L. M. Newman, and L. S. Wallace, "Literacy Demands and Formatting Characteristics of Opioid Contracts in Chronic Nonmalignant Pain Management Journal of Pain 8, no. 10 (2007 753 758, at 757.
27. E. J. Cassell, A. C. Leon, and S. G. Kaufman, "Preliminary Evidence of Impaired Thinking in Sick Patients Annals of Internal Medicine 134 (2001 1120 1123, at 1120.
28. See American Jurisprudence, supra note 18, at 62-3.
29. M. Collen, "The Case for Pain Insomnia Depression Syndrome (PIDS): A Symptom Cluster in Chronic Nonmalignant Pain Journal of Pain and Palliative Care Pharmacotherapy 22, no. 3 (2008 221 225, at 222-3.
30. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (Arlington : American Psychiatric Association, 2000 at 377, 599.
31. See Fishman et al., supra note 2, at 27; Arnold et al., supra note 3, at 292; Fishman et al., supra note 9, S70; Fishman et al., supra note 11, at 297.
32. See Arnold et al., supra note 3, at 293.
33. J. W. Berg, P. S. Appelbaum, C. W. Lidz, and L. S. Parker, Informed Consent: Legal Theory and Clinical Practice, 2nd ed. (New York : Oxford University Press, 2001 at 53, 65-70, 95, 308.
34. See Fishman et al., supra note 2, at 31.
35. See Nafziger et al., supra note 3, at 73; Reisfield et al., supra note 4, at 301; Heit et al., supra note 4, at 260; Katz, Sherburne et al., supra note 5, at 1097.
36. See Reisfield et al., supra note 4, at 301; Fishman et al., supra note 11, at 298.
37. See Heit et al., supra note 4, at 260.
38. See Reisfield et al., supra note 4, at 303; Fishman et al., supra note 11, at 298.
39. See Fishman et al., supra note 11, at 298.
40. Id.
41. R. Chou, G. J. Fanciullo, P. G. Fine, C. Miaskowski, S. D. Passik, and R. K. Portenoy, "Opioids for Chronic Noncancer Pain: Prediction and Identification of Aberrant Drug-Related Behaviors: A Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline Journal of Pain 10, no. 2 (2009 131 146, at 137.
42. See Nafziger et al., supra note 3, at 74; Fishman et al, supra note 11, at 297.
43. See Nafziger et al., supra note 3, at 74.
44. See Reisfield et al., supra note 4, at 312.
45. H. Smith, S. Fishman, and J. Audette, Opioid Therapy: Controversies and Considerations. 21st Annual Scientific Meeting of the American Pain Society, formerly at http://www.medscape.com/viewarticle433604 last visited January 23, 2009) (link no longer available, article on file with author); see Nafziger et al., supra note 3, at 77; Heit et al., supra note 4, at 262; Fishman et al., supra note 11, at 298.
46. See Nafziger et al., supra note 3, at 76.
47. See Reisfield et al., supra note 4, at 307; Heit et al., supra note 4, at 263.
48. See Katz and Fanciullo et al., supra note 5, at S79.
49. See Nafziger et al., supra note 3, at 76.
50. See Katz, Fanciullo et al., supra note 5, at S80.
51. See Heit et al., supra note 4, at 264.
52. Id., at 265.
53. See Katz, Fanciullo et al., supra note 5, at S79.
54. See Reisfield et al., supra note 4, at 307.
55. See Heit et al., supra note 4, at 263.
56. See Fishman et al., supra note 11, at 299.
57. Id.
58. See Reisfield et al., supra note 4, at 312.
59. R. Chou, J. C. Ballantyne, G. J. Fanciullo, P. G. Fine, and C. Miaskowski, "Research Gaps on Use of Opioids for Chronic Noncancer Pain: Findings from a Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline Journal of Pain 10, no. 2 (2009 147 159, at 152; see Nafziger et al., supra note 3, at 78; Reisfield et al., supra note 4, at 312; Heit et al., supra note 4, at 263; Katz, Fanciullo et al., supra note 5, at S79-81; Fishman et al., supra note 11, at 297-301; Chou et al., supra note 34, at 137; Smith et al., supra note 38.
60. See Schei, supra note 15, at 401-2.
61. See Katz and Fanciullo et al., supra note 5, at S80; Smith et al., supra note 38.
62. See Heit et al., supra note 4, at 261.
63. D. H. Thom, M. A. Hall, and L. G. Pawlson, "Measuring Patients' Trust in Physicians When Assessing Quality of Care Health Affairs 23, no. 4 (2004 124 132, at 127.
64. C. A. Barry, C. P. Bradley, N. Britten, F. A. Stevenson, and N. Barber, "Patients' Unvoiced Agendas in General Practice Consultations: Qualitative Study BMJ 320 (2000 1246 1250, at 1246, 1250. (Pubitemid 30240475)
65. F. Benedetti, "How the Doctor's Words Affect the Patient's Brain Evaluation & the Health Professions 25, no. 4 (2002 369 386, at 370, 372, 382; K. B. Thomas, "General Practice Consultations: Is there any Point in Being Positive?" British Medical Journal 294 (1987): 1200-2, at 1201.
66. Y. Y. Lee and J. L. Lin, "The Effects of Trust in Physician on Self-efficacy, Adherence and Diabetes Outcomes Social Science Medicine 68, no. 6 (2009 1060 1068, at 1060-1, 1066-7; D. E. Bonds, F. Camacho, R. A. Bell, V. T. Duren-Winfield, R. T. Anderson, and D. C. Goff, "The Association of Patient Trust and Self-Care among Patients with Diabetes Mellitus," BMC Family Practice 5 (2004): 26; see Thom et al., supra note 56, at 124.
67. D. H. Thom, R. L. Kravitz, R. A. Bell, E. Krupat, and R. Azari, "Patient Trust in the Physician: Relationship to Patient Requests Family Practice 19, no. 5 (2002 476 483, at 483.
68. L. R. Churchill and D. Schenck, "Healing Skills for Medical Practice Annals of Internal Medicine 149 (2008 720 724, at 720.
69. H. C. Weng, "Does the Physician's Emotional Intelligence Matter? Impacts of the Physician's Emotional Intelligence on the Trust, Patient-physician Relationship, and Satisfaction Health Care Management Review 33, no. 4 (2008 280 288, at 280; see Thom et al., supra note 56, at 125; Lee at al., supra note 59, at 1061.
70. S. H. Kaplan, S. Greenfield, and J. E. Ware Jr., "Assessing the Effects of Physician-Patient Interactions on the Outcomes of Chronic Disease Medical Care 27, no. 3, supplement (1989 S110 27, at S124; see Schei, supra note 15, at 398; Churchill et al., supra note 61, at 720.
71. D. M. Goldenbaum, M. Christopher, R. M. Gallagher, S. Fishman, R. Payne, D. Joranson, D. Edmonson, J. McKee, and A. Thexton, "Physicians Charged with Opioid Analgesic-Prescribing Offenses Pain Medicine 9, no. 6 (2008 737 747, at 741.
72. D. Vaczek, "Top 200 Prescription Drugs of 2003 Pharmacy Times 70, no. 7 (2004 46 54, at 47; D. Vaczek, "Top 200 Prescription Drugs of 2004," Pharmacy Times 71, no. 5 (2005): 41-6, at 42; "Top 200 Prescription Drugs of 2005," Pharmacy Times 72, no. 5 (2006): 26-30, at 27; E. Lamb, "Top 200 Prescription Drugs of 2006," Pharmacy Times 73, no. 5 (2007): 34-7, at 35; E. Lamb, "Top 200 Prescription Drugs of 2007," Pharmacy Times 74, no. 5 (2008): 20-3, at 21.
73. Substance Abuse and Mental Health Services Administration, Results from the 2007 National Survey on Drug Use and Health: National Findings (2008) (Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08-4343): at 17, 18.
74. Id., at 6, 16.
75. M. Weaver and S. Schnoll, "Abuse Liability in Opioid Therapy for Pain Treatment in Patients with an Addiction History Clinical Journal of Pain 18, no. 4, supplement (2002 S61 9, at S61.
76. Pain & Policy Studies Group, Achieving Balance in State Pain Policy: A Progress Report Card, 4th ed. (Madison : Pain & Policy Studies Group, University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, 2008 at 2, 5.
77. See Spanswick, supra note 15, at 94-6; Dibben et al., supra note 15, at 55; Schei, supra note 15, at 397.
78. See Breuer et al., supra note 16, at 244, 248.
79. See Katz and Fanciullo et al., supra note 5, at S80; Gourlay et al., et al., supra note 5, at 109.